IL-33 immunoadjuvant (Inovio)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameIL-33 immunoadjuvant (Inovio)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy > Plasmid
Mechanisms of ActionInterleukin-33 stimulants
TargetsInterleukin-33
Therapy Area/IndicationsVaccination
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInovio Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInovio Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsVaccination

Other Information

ATC CodeN/A
Related LinksN/A